This site is intended for healthcare professionals only
LoginRegister
Aurobindo Pharma Extends Timeline to Acquire 26% in Swarnaakshu SolarAurobindo Pharma arm announces successful Phase 1 clinical study outcome of their BP11 product
Lupin and TB Alliance Join Forces to Advance TelacebecLupin gets one USFDA observation for Aurangabad facility
After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug NereusZydus Lifesciences gets USFDA okay for Finasteride and Tadalafil Capsules
Syngene International, Bristol Myers Squibb Extend Strategic Collaboration Through 2035Syngene biologics manufacturing facility to be operational for US, European customers from mid year
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca Gets CDSCO Panel Nod to Study anticancer drug Volrustomig
Bad Times for Sanofi Healthcare? Market Signals Suggest Growing PressureCDSCO Panel Approves Sanofi's Protocol Amendment Proposal For Study of SAR443122 in Ulcerative...
Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid TariffsNeed More Justification: CDSCO Panel rejects J&J protocol amendment proposal for Teclistamab study
Novartis concludes acquisition of Tourmaline BioModify Clinical study protocol of Iptacopan study in aHUS: CDSCO Panel Tell Novartis
Ionis announces positive results from Phase 2 study of ION224 to treat NASH/MASHIonis announces positive results from Phase 2 study of ION224 to treat NASH/MASH
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationBayer, Aignostics to collaborate on next generation precision oncology
RocheCDSCO Panel Grants Roche's Protocol Amendment Proposal For Crovalimab study
Pfizer Awards Rs 60 Lakh Each to 14 Healthtech Startups Under INDovation 2025CDSCO Panel grants Pfizer's Protocol Amendment for Anti-cancer Drug Palbociclib study
X